Aortic stenosis surgery indications

Revision as of 16:36, 12 November 2011 by Mohammed Sbeih (talk | contribs)
Jump to navigation Jump to search

Aortic stenosis surgery

Home

Overview

Epidemiology and Demographics

Indications

Treatment

Preoperative Evaluation

Procedure

Recovery

Outcomes and Prognosis

Complications

Videos

Aortic stenosis surgery indications On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Aortic stenosis surgery indications

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Aortic stenosis surgery indications

CDC on Aortic stenosis surgery indications

Aortic stenosis surgery indications in the news

Blogs on Aortic stenosis surgery indications

Directions to Hospitals Performing Aortic stenosis Surgery

Risk calculators and risk factors for Aortic stenosis surgery indications

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-In-Chief: Mohammed A. Sbeih, M.D. [2]

Overview

Aortic stenosis requires aortic valve replacement if medical management does not successfully control symptoms. According to a prospective, single-center, nonrandomized study of 25 patients, percutaneous implantation of an aortic valve prosthesis in high risk patients with aortic stenosis results in marked hemodynamic and clinical improvement when successfully completed.[1]

Indications

ACC/AHA Guidelines- Indications for Surgery for Aortic Stenosis (DO NOT EDIT) [2]

Class I

1. (Level of Evidence: B)

2. (Level of Evidence: C)

Class IIa

1.(Level of Evidence: C)

Class IIb

1. (Level of Evidence: C)

Class III

1.(Level of Evidence: C)

2. (Level of Evidence: C)

Sources

  • 2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease [2].

References

  1. Grube E, Laborde JC, Gerckens U; et al. (2006). "Percutaneous implantation of the CoreValve self-expanding valve prosthesis in high-risk patients with aortic valve disease: the Siegburg first-in-man study". Circulation. 114 (15): 1616–24. doi:10.1161/CIRCULATIONAHA.106.639450. PMID 17015786.
  2. 2.0 2.1 Bonow RO, Carabello BA, Chatterjee K, de Leon AC, Faxon DP, Freed MD; et al. (2008). "2008 focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1998 guidelines for the management of patients with valvular heart disease). Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons". J Am Coll Cardiol. 52 (13): e1–142. doi:10.1016/j.jacc.2008.05.007. PMID 18848134.

Template:WH Template:WS